|
UHMK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.23139999999677E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
5.136000E-01 |
| Stage1-vs-Stage3 |
2.832000E-02 |
| Stage1-vs-Stage4 |
3.898100E-03 |
| Stage2-vs-Stage3 |
8.222400E-02 |
| Stage2-vs-Stage4 |
2.651600E-02 |
| Stage3-vs-Stage4 |
4.433200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.585880E-02 |
| Caucasian-vs-AfricanAmerican |
1.100530E-03 |
| Caucasian-vs-Asian |
3.984200E-01 |
| AfricanAmerican-vs-Asian |
2.183800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.063600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02460000039883E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62669877568078E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.34139996069649E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.933200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.503800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.632200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.986370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.977400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.326200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.85529999999457E-05 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
8.344600E-01 |
| Grade 1-vs-Grade 3 |
6.255200E-01 |
| Grade 1-vs-Grade 4 |
1.442790E-01 |
| Grade 2-vs-Grade 3 |
4.056000E-01 |
| Grade 2-vs-Grade 4 |
8.057700E-03 |
| Grade 3-vs-Grade 4 |
5.050300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62680979798324E-12 |
| Normal-vs-ccB subtype |
3.28825855433479E-12 |
| ccA subtype-vs-ccB subtype |
4.206600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62481139653892E-12 |
| Normal-vs-N1 |
2.584200E-02 |
| N0-vs-N1 |
6.843800E-01 |
|
|
